Table 1 Characteristics of the centers that participated in the survey
Answer options | n (%) |
|---|---|
Number of patients treated on a monthly basis with Onabotulinumtoxin A (OBT-A) | |
< 5 patients | 15 (23.8) |
5−10 patients | 21 (33.3) |
10−20 patients | 18 (28.6) |
20−40 patients | 5 (7.9) |
> 40 patients | 4 (6.4) |
Years of experience with OBT-A for chronic migraine | |
> 1 year and ≤3 years | 39 (61.9) |
> 3 years | 24 (38.1) |
Longest follow-up of patients treated with OBT-A for chronic migraine | |
1 year | 13 (20.6) |
2 years | 24 (38.1) |
3 years | 18 (28.6) |
≥ 4 years | 8 (12.7) |
Availability of electronic data recording system | |
Yes | 45 (71.4) |
No | 18 (28.6) |
Availability of a facility dedicated to the treatment of chronic migraine with OBT-A | |
Yes | 51 (81.9) |
No | 12 (19.1) |